Product Description for NDRG2
Rabbit anti Bovine, Canine, Equine, Guinea Pig, Human, Mouse, Porcine, Rabbit, Rat NDRG2.
Presentation: Purified
Product is tested for Paraffin Sections, Western blot / Immunoblot.
Presentation: Purified
Product is tested for Paraffin Sections, Western blot / Immunoblot.
Properties for NDRG2
| Product Category | Primary Antibodies |
|---|---|
| Quantity | 0.1 ml |
| Synonyms | KIAA1248, SYLD |
| Presentation | Purified |
| Reactivity | Bov, Can, Eq, GP, Hu, Ms, Por, Rb, Rt |
| Applications | P, WB |
| Clonality | Polyclonal |
| Host | Rabbit |
| Isotype | IgG |
| Shipping to | Europe, USA/Canada |
| PDF datasheet | View Datasheet |
| Manufacturer | OriGene Technologies, Inc. |
Datasheet Extract
| Immunogen |
|
|---|---|
| Application | WB IHC |
| Background | This gene is a member of the N-myc downregulated gene family which belongs to the alpha/beta hydrolase superfamily. The protein encoded by this gene is a cytoplasmic protein that may play a role in neurite outgrowth. This gene may be involved in glioblastoma carcinogenesis. Several altertively spliced transcript variants of this gene have been described, but the full-length ture of some of these variants has not been determined. [provided by RefSeq, Jul 2008]. |
| Format |
|
Accessory Products
Proteins and/or Positive Controls
Proteins for NDRG2 (17 products)
| Catalog No. | Species | Pres. | Purity | Source | |||
|---|---|---|---|---|---|---|---|
| TP303712 |
NDRG2 (transcript variant 5) |
||||||
|
Human |
> 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|||
| OriGene Technologies, Inc. | |||||||
| TP310598 |
NDRG2 (transcript variant 8) |
||||||
|
Human |
> 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|||
| OriGene Technologies, Inc. | |||||||
| TP311577 |
NDRG2 (transcript variant 2) |
||||||
|
Human |
> 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|||
| OriGene Technologies, Inc. | |||||||
| TP312237 |
NDRG2 (transcript variant 4) |
||||||
|
Human |
> 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|||
| OriGene Technologies, Inc. | |||||||
| TP314708 |
NDRG2 (transcript variant 7) |
||||||
|
Human |
> 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|||
| OriGene Technologies, Inc. | |||||||
| TP319812 |
NDRG2 (transcript variant 1) |
||||||
|
Human |
> 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|||
| OriGene Technologies, Inc. | |||||||
| TP320003 |
NDRG2 (transcript variant 6) |
||||||
|
Human |
> 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|||
| OriGene Technologies, Inc. | |||||||
| TP760733 |
NDRG2 (full length, N-term HIS tag, transcript variant 3) |
||||||
|
Human |
> 80 % Preparation: . Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
E. coli |
50 µg /
€205.00
|
|||
| OriGene Technologies, Inc. | |||||||
| AR50516PU-N |
NDRG2 (1-357, His-tag) |
||||||
|
Human | Purified | > 90 % by SDS - PAGE | E. coli |
0.5 mg /
€820.00
|
||
| OriGene Technologies GmbH | |||||||
| AR50516PU-S |
NDRG2 (1-357, His-tag) |
||||||
|
Human | Purified | > 90 % by SDS - PAGE | E. coli |
0.1 mg /
€320.00
|
||
| OriGene Technologies GmbH | |||||||
| H00057447-P01-10 |
NDRG2 |
||||||
|
Human | Purified | 12.5% SDS-PAGE Stained with Coomassie Blue. | ||||
| Abnova Taiwan Corp. | |||||||
| H00057447-P01-25 |
NDRG2 |
||||||
|
Human | Purified | 12.5% SDS-PAGE Stained with Coomassie Blue. | ||||
| Abnova Taiwan Corp. | |||||||
| H00057447-P02 |
NDRG2 |
||||||
|
Human | Purified | |||||
| Abnova Taiwan Corp. | |||||||
| H00057447-P02-10 |
NDRG2 |
||||||
|
Human | Purified | 12.5% SDS-PAGE Stained with Coomassie Blue. | ||||
| Abnova Taiwan Corp. | |||||||
| H00057447-P02-25 |
NDRG2 |
||||||
|
Human | Purified | 12.5% SDS-PAGE Stained with Coomassie Blue. | ||||
| Abnova Taiwan Corp. | |||||||
| H00057447-Q01-10 |
NDRG2 |
||||||
|
Human | 12.5% SDS-PAGE Stained with Coomassie Blue. | in vitro transl. | ||||
| Abnova Taiwan Corp. | |||||||
| H00057447-Q01-25 |
NDRG2 |
||||||
|
Human | 12.5% SDS-PAGE Stained with Coomassie Blue. | in vitro transl. | ||||
| Abnova Taiwan Corp. | |||||||
Positive controls for NDRG2 (17 products)
| Catalog No. | Species | Pres. | Purity | Source | |||
|---|---|---|---|---|---|---|---|
| H00057447-T01 |
NDRG2 293T Cell Transient Overexpression Lysate(Denatured) |
||||||
![]() |
|||||||
| Abnova Taiwan Corp. | |||||||
| NBL1-13530 |
NDRG2 Lysate |
||||||
![]() |
|||||||
| Novus Biologicals Inc. | |||||||
| NBL1-13531 |
NDRG2 Lysate |
||||||
![]() |
|||||||
| Novus Biologicals Inc. | |||||||
| LY404442 |
NDRG2 overexpression lysate |
||||||
![]() |
0.1 mg /
€295.00
|
||||||
| OriGene Technologies, Inc. | |||||||
| LY404443 |
NDRG2 overexpression lysate |
||||||
![]() |
0.1 mg /
€295.00
|
||||||
| OriGene Technologies, Inc. | |||||||
| LY404444 |
NDRG2 overexpression lysate |
||||||
![]() |
0.1 mg /
€295.00
|
||||||
| OriGene Technologies, Inc. | |||||||
| LY404445 |
NDRG2 overexpression lysate |
||||||
![]() |
0.1 mg /
€295.00
|
||||||
| OriGene Technologies, Inc. | |||||||
| LY404446 |
NDRG2 overexpression lysate |
||||||
![]() |
0.1 mg /
€295.00
|
||||||
| OriGene Technologies, Inc. | |||||||
| LY404447 |
NDRG2 overexpression lysate |
||||||
![]() |
0.1 mg /
€295.00
|
||||||
| OriGene Technologies, Inc. | |||||||
| LY404448 |
NDRG2 overexpression lysate |
||||||
![]() |
0.1 mg /
€295.00
|
||||||
| OriGene Technologies, Inc. | |||||||
| LY414093 |
NDRG2 overexpression lysate |
||||||
![]() |
0.1 mg /
€295.00
|
||||||
| OriGene Technologies, Inc. | |||||||
| LY430865 |
NDRG2 overexpression lysate |
||||||
![]() |
0.1 mg /
€315.00
|
||||||
| OriGene Technologies, Inc. | |||||||
| LY430866 |
NDRG2 overexpression lysate |
||||||
![]() |
0.1 mg /
€315.00
|
||||||
| OriGene Technologies, Inc. | |||||||
| LY430867 |
NDRG2 overexpression lysate |
||||||
![]() |
0.1 mg /
€315.00
|
||||||
| OriGene Technologies, Inc. | |||||||
| LY430868 |
NDRG2 overexpression lysate |
||||||
![]() |
0.1 mg /
€315.00
|
||||||
| OriGene Technologies, Inc. | |||||||
| LY430869 |
NDRG2 overexpression lysate |
||||||
![]() |
0.1 mg /
€315.00
|
||||||
| OriGene Technologies, Inc. | |||||||
| LY430870 |
NDRG2 overexpression lysate |
||||||
![]() |
0.1 mg /
€315.00
|
||||||
| OriGene Technologies, Inc. | |||||||
Recommended Secondary Antibodies for NDRG2 (9 products)
| Catalog No. | Host | Clone/Iso. | Pres. | React. | Applications | ||
|---|---|---|---|---|---|---|---|
| R1364AP |
Rabbit IgG (H+L chain) antibody |
||||||
|
Goat | AP | Rb | E, WB | |||
| OriGene Technologies GmbH | |||||||
| R1364B |
Rabbit IgG (H+L chain) antibody |
||||||
|
Goat | Biotin | Rb | E, WB | |||
| OriGene Technologies GmbH | |||||||
| R1364F |
Rabbit IgG (H+L chain) antibody |
||||||
|
Goat | FITC | Rb | E, ICC/IF, WB | |||
| OriGene Technologies GmbH | |||||||
| R1364HRP |
Rabbit IgG (H+L chain) antibody |
||||||
|
Goat | HRP | Rb | E, P, WB | |||
| OriGene Technologies GmbH | |||||||
| R1364T |
Rabbit IgG (H+L chain) antibody |
||||||
|
Goat | TRITC | Rb | E, F, ICC/IF | |||
| OriGene Technologies GmbH | |||||||
| R1427R |
Rabbit IgG F(ab)2 Fragment (H+L chain) antibody |
||||||
|
Donkey | PE | Rb | F | |||
| OriGene Technologies GmbH | |||||||
| R1458C2 |
Rabbit IgG (H+L chain, adsorbed) antibody |
||||||
|
Goat | Cy2 | |||||
| OriGene Technologies GmbH | |||||||
| R1458C3 |
Rabbit IgG (H+L chain, adsorbed) antibody |
||||||
|
Goat | Cy3 | |||||
| OriGene Technologies GmbH | |||||||
| R1458C5 |
Rabbit IgG (H+L chain, adsorbed) antibody |
||||||
|
Goat | Cy5 | |||||
| OriGene Technologies GmbH | |||||||
![Western Blot: NDRG2 Lysate [NBL1-13530] - Western Blot experiments.
Left-Control; Right -Over-expression Lysate for NDRG2](https://m1.acris-antibodies.com/catalog/product/cache/1/small_image/50x50/9df78eab33525d08d6e5fb8d27136e95/Novus/NDRG2%20Lysate-Western%20Blot-NBL1-13530-img0001.jpg)
![Western Blot: NDRG2 Lysate [NBL1-13531] - Western Blot experiments.
Left-Control; Right -Over-expression Lysate for NDRG2](https://m1.acris-antibodies.com/catalog/product/cache/1/small_image/50x50/9df78eab33525d08d6e5fb8d27136e95/Novus/NDRG2%20Lysate-Western%20Blot-NBL1-13531-img0001.jpg)
